Second Genome Partners with American Gut | GenomeWeb

NEW YORK (GenomeWeb News) – Microbial biomarker technologies developer Second Genome has undertaken an initiative with American Gut, a multi-partner effort to characterize the microbial diversity of the gut, to study the possible roles the human microbiome may play in type 2 diabetes.

Under the initiative, Second Genome made a donation to American Gut of an undisclosed amount to fund specimen collection for participants who have type 2 diabetes, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.